Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;57(1):109.
doi: 10.1186/s41983-021-00363-8. Epub 2021 Aug 4.

Neurological manifestations in mild and moderate cases of COVID-19

Ghada Saed Abdel Azim  1 , Marwa Abdellah Osman  1
Affiliations

Neurological manifestations in mild and moderate cases of COVID-19

Ghada Saed Abdel Azim et al. Egypt J Neurol Psychiatr Neurosurg. 2021.

Abstract

Background: The coronavirus disease due to SARS COVID-2 emerged from Wuhan city in China in December 2019 and rapidly spread to more than 200 countries all over the world as a global health pandemic. Its primary presentation is respiratory and cardiac. However, some neurological manifestations are also reported. We tried to explore the reported neurological manifestations in a group of non-hospitalized mild and moderate COVID-19 patients. We contacted 107 patients via phone calls and e-mail messages, within 10 days of clinical presentation. The collected data regarded the neurological and non-neurological symptoms of the disease using a questionnaire that collected medical information of each patient.

Results: It is found that 100% of patients have been reported with at least one neurological symptom during the first 10 days of COVID-19 presentation. The most common were headache which recorded 72% of the total. Then anosmia-dysgeusia which reached 52%, then myalgia with 44%, fatigue with 33% and dizziness with 32%. While the less common was numbness, migraine, loss of concentration, and seizures.

Conclusion: There are many neurological manifestations found to be very common in COVID-19 patients even in mild cases, which when added to the increasing reports of serious cases of Guillain-Barre syndrome, acute necrotizing encephalopathy, myelitis, stroke, and encephalitis in COVID-19 patients support CNS invasion of the virus and assures the importance of neurological assessment of COVID-19 patients both in the acute phase of infection and after recovery for potential neurological sequelae.

Keywords: COVID-19; Home-isolated patients; Neurological manifestations.

PubMed Disclaimer

Conflict of interest statement

Competing interestsNone of the authors has any competing interests.

Figures

Fig. 1
Fig. 1
Neurological manifestations associated with COVID-19
Fig. 2
Fig. 2
Peripheral nervous system manifestations
Fig. 3
Fig. 3
Central nervous system manifestations
See this image and copyright information in PMC

References

    1. Nepal G, Rehrig JH, Shrestha GS, Shing YK, Yadav JK, Ojha R, et al. Neurological manifestations of COVID-19: a systematic review. Crit Care. 2020;24:421. doi: 10.1186/s13054-020-03121-z. - DOI - PMC - PubMed
    1. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;10:875–882. doi: 10.1016/S2215-0366(20)30287-X. - DOI - PMC - PubMed
    1. Ahmad I, Rathore F. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8–12. doi: 10.1016/j.jocn.2020.05.017. - DOI - PMC - PubMed
    1. Garcia-Monco JC, Muras CA, Iriarte EM, Armenteros RP, Fernández CA, Arranz-Martínez J, et al. Neurological manifestations in a prospective unselected series of hospitalized COVID-19 patients. Neurology Clin Pract. 2020;11:e64. doi: 10.1212/CPJ.0000000000000913. - DOI - PMC - PubMed
    1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127. - DOI - PMC - PubMed

LinkOut - more resources